Log In
Print
BCIQ
Print
Print this Print this
 

PWT143

  Manage Alerts
Collapse Summary General Information
Company Pathway Therapeutics Inc.
DescriptionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) delta
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

MEI Pharma Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today